News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Yamanouchi Pharmaceutical Co., Ltd. , Keio University Discover Target Molecule For Anti-obesity And Antidiabetic Drug



10/19/2005 5:13:07 PM

Tokyo (JCNN) - Yamanouchi Pharmaceutical (TSE: 4503) announced that it has discovered a promising target molecule for the development of anti-obesity and antidiabetic drug, in collaboration with Keio University. Through mice experiments, the joint research group has confirmed that an Angiopoietin-related growth factor (AGF) has properties to improve obesity and diabetic symptoms. AGF is a protein secreted by liver.

Read at JCN Newswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES